Page 27 - The DHEA Debate - Life Extensions Magazine
P. 27

inflammatory disease: role of interleukin-6 and tumor necrosis factor. Eur J Endocrinol. 2002
               Mar; 146(3):365-74.
               143. Vogl D, Falk W, Dorner M, Scholmerich J Straub RH. Serum levels of pregnenolone and
               17-hydroxypregnenolone in patients with rheumatoid arthritis and systemic lupus erythematosis:
               relation to other adrenal hormones. J Rheumatol. 2003 Feb;30(2):269-75.

               144. Cutolo M, Strab RH, Foppiani L, et al. Adrenal gland hypofunction in active polymyalgia
               rheumatica; effect of glucocorticoid treatment on adrenal hormones and interleukin-6. J
               Rheumatol. 2002 Apr; 29(4):748-56.
               145. Andus T, Klebl F, Rogler G, Bregenzer N, Scholmerich J, Straub RH. Patients with
               refractory Crohn’s disease or ulcerative colitis respond to dehydroepiandrosterone: a pilot study.
               Aliment Pharmacol Ther. 2003 Feb; 17(3):409-14.
               146. Straub RH, Scholmerich J, Zietz B. Replacement therapy with DHEA plus corticosteroids in
               patients with chronic inflammatory diseases – substitutes of adrenal and sex hormones. Z
               Rheumatol. 2002; 59:Suppl 2:108-118.

               147. Osorio A, Vara-Thorbeck R, Rosell J, Osorio C, Ortega E, Ruiz-Requena E.
               Dehydroepiandrosterone sulfate and growth axis hormones in patients after surgery. World J
               Surg. 2002 Sep;26(9):1079-82. Epub 2002 Aug 16.

               148. Canbaz S, EgeT, Sunar H, Cikirikcioglu M, Acipayam M, Duran E. The effects of
               cardiopulmonary bypass on androgen hor- mones in coronary artery bypass surgery. J Int Med
               Res. 2002 Jan-Feb; 30(1):9-14.
               149. National Institute of Mental Health. Depression. Available at: http://
               www.nimh.nih.gov/publicat/depression.
               com. Accessed January 13, 2004.

               150. Wolkowitz OM, Reus VI. Neurotransmitters, neurosteroids and neurotrophins: new models
               of the patho- physiology and treatment of depression. World J Biol Psychiatry. 2003 Jul;4(3):98-
               102. 151. Young AH, Gallagher P, Porter RJ. Elevation of the cortisol-dehydroepiandrosterone
               ratio in drug-free depressed patients. Am J Psychiatry. 2002 Jul;159(7):1237-9.
               152. Giordano R, DiVito L, Lanfranco F, et al. Elderly subjects show severe impairment of
               dehydroepiandrosterone sulfate and reduced sensitivity of cortisol and aldosterone response to
               the stimulatory effect of ACTH. Clin Endocrinol. (Oxf) 2001 Aug;55(2):259-65.

               153. Weill-Engerer S, David JP, Sazdovitch V, et al. Neurosteroid quantification in human brain
               regions; comparison between Alzheimer’s and nondemented patients. J Clin Endocrinol Metab.
               2002 Nov; 87(11):5138-43.
               154. Valenti G. Andrenopause: an imbalance between dehydroepiandrosterone (DHEA) and
               cortisol secretion. J Endocrinol Invest. 2002;25(10 suppl):25- 35.

               155. Magri F, Terenzi F, Ricciardi T, et al. Association between changes in adrenal secretion
               and cerebral morphometric cor- relates in normal aging and senile dementia. Dement Geriatr
               Cogn Disord. 2000 Mar-Apr; 11(2):90-9.
               156. Karishma KK, Herbert J. Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the
               hippocampus of the rat, promotes survival of newly formed neurons and prevents
               corticosterone- induced suppression. Eur J Neurosci. 2002 Aug;16(3):445-53.
   22   23   24   25   26   27   28